Denosumab Response in Glucocorticoid-Induced Osteoporosis Resistant to Bisphosphonate Therapy in an Adolescent with Childhood Onset Minimal Change Disease - A Case Report
Glucocorticoid induced osteoporosis is difficult to treat in patients with nephrotic syndrome. The efficacy and safety of denosumab in pediatric population is unknown. We report the successful use of denosumab in a child who was non responsive to conventional measures and bisphosphonates.
Authors
- Sanjeev Gulati (ORCID: https://orcid.org/0000-0002-1778-7693)
- Sanshriti Chauhan (ORCID: https://orcid.org/0000-0001-7385-5614)
Publication Details
- Journal
- Indian Journal of Nephrology
- Published
- 2024-10-25
- DOI
- https://doi.org/10.25259/ijn_474_2024
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00